HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients

  • Nahoko Kaniwa
  • , Yoshiro Saito
  • , Michiko Aihara
  • , Kayoko Matsunaga
  • , Masahiro Tohkin
  • , Kouichi Kurose
  • , Hirokazu Furuya
  • , Yukitoshi Takahashi
  • , Masaaki Muramatsu
  • , Shigeru Kinoshita
  • , Masamichi Abe
  • , Hiroko Ikeda
  • , Mariko Kashiwagi
  • , Yixuan Song
  • , Mayumi Ueta
  • , Chie Sotozono
  • , Zenro Ikezawa
  • , Ryuichi Hasegawa

Research output: Contribution to journalArticlepeer-review

219 Citations (Scopus)

Abstract

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but life-threatening severe cutaneous adverse reactions. Recently, strong associations of HLA-B*1502 with carbamazepine-induced SJS/TEN have been found in Han Chinese patients. These associations have been confirmed in several Asian populations, excluding Japanese. SJS patients carrying HLA-B*1508, HLA-B*1511, or HLA-B*1521, which are members of the HLA-B75 type along with HLA-B*1502, were detected in studies in India and Thailand. In the current study, we genotyped the HLA-B locus from 14 Japanese typical and atypical SJS/TEN patients in whom carbamazepine was considered to be involved in the onset of adverse reactions. Although there were no HLA-B*1502 carriers, four patients had HLA-B*1511. Our data suggest that HLA-B*1511, a member of HLA-B75, is a risk factor for carbamazepine- induced SJS/TEN in Japanese.

Original languageEnglish
Pages (from-to)2461-2465
Number of pages5
JournalEpilepsia
Volume51
Issue number12
DOIs
Publication statusPublished - 12-2010
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients'. Together they form a unique fingerprint.

Cite this